NCT05977257View on ClinicalTrials.gov

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）

Not yet recruitingOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

July 30, 2023

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2028

Conditions
Aortic Valve DiseaseAortic Valve Stenosis
Interventions
DEVICE

VitaFlow® Transcatheter Aortic Valve Replacement System

This study is an observational study, for who have joined the VitaFlow® Catheter Aortic Valve System pre-market trial

Trial Locations (4)

Unknown

Fuwai CVD Hospital of Chinese Academy of Medical Sciences, Beijing

West China Hospital, Sichuan University, Chengdu

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Zhongshan Hospital Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai MicroPort CardioFlow Medtech Co., Ltd.

INDUSTRY